REVIEW ARTICLE
Pharmacologic stress cardiovascular magnetic resonance in the pediatric population: A review of the literature, proposed protocol, and two examples in patients with Kawasaki disease
Munes Fares MD,
Paul J. Critser MD, PhD,
Maria J. Arruda MD,
Carolyn M. Wilhelm MD,
Mantosh S. Rattan MD,
Sean M. Lang MD,
Tarek Alsaied MD, MSc,
Munes Fares MD
Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
Search for more papers by this authorPaul J. Critser MD, PhD
Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Search for more papers by this authorMaria J. Arruda MD
Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
Search for more papers by this authorCarolyn M. Wilhelm MD
Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
Search for more papers by this authorMantosh S. Rattan MD
Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Search for more papers by this authorSean M. Lang MD
Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio
Search for more papers by this authorCorresponding Author
Tarek Alsaied MD, MSc
Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio
Correspondence
Tarek Alsaied, Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, MLC 2003, 3333 Burnet Avenue, Cincinnati, OH 45229-3039.
Email: [email protected]
Search for more papers by this authorMunes Fares MD,
Paul J. Critser MD, PhD,
Maria J. Arruda MD,
Carolyn M. Wilhelm MD,
Mantosh S. Rattan MD,
Sean M. Lang MD,
Tarek Alsaied MD, MSc,
Munes Fares MD
Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
Search for more papers by this authorPaul J. Critser MD, PhD
Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Search for more papers by this authorMaria J. Arruda MD
Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
Search for more papers by this authorCarolyn M. Wilhelm MD
Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
Search for more papers by this authorMantosh S. Rattan MD
Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Search for more papers by this authorSean M. Lang MD
Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio
Search for more papers by this authorCorresponding Author
Tarek Alsaied MD, MSc
Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio
Correspondence
Tarek Alsaied, Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, MLC 2003, 3333 Burnet Avenue, Cincinnati, OH 45229-3039.
Email: [email protected]
Search for more papers by this authorAbstract
Pharmacologic stress cardiovascular magnetic resonance (PSCMR) is a well-established and reliable diagnostic tool for evaluation of coronary artery disease in the adult population. Stress imaging overall and PSCMR in particular is less utilized in the pediatric population with limited reported data. In this review, we highlight the potential use of PSCMR in specific pediatric cohorts with congenital and acquired heart disease, and we review the reported experience. A suggested protocol is presented in addition to two case examples of patients with Kawasaki disease where PSCMR aided decision making.
REFERENCES
- 1Kato S, Saito N, Nakachi T, et al. Stress perfusion coronary flow reserve versus cardiac magnetic resonance for known or suspected CAD. J Am Coll Cardiol. 2017; 70(7): 869-879.
- 2Buckert D, Witzel S, Steinacker JM, Rottbauer W, Bernhardt P. Comparing cardiac magnetic resonance-guided versus angiography-guided treatment of patients with stable coronary artery disease: results from a prospective randomized controlled trial. JACC Cardiovasc Imaging. 2018; 11(7): 987-996.
- 3Vincenti G, Masci PG, Monney P, et al. Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization. JACC Cardiovasc Imaging. 2017; 10(5): 526-537.
- 4Manka R, Wissmann L, Gebker R, et al. Multicenter evaluation of dynamic three-dimensional magnetic resonance myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve. Circ Cardiovasc Imaging. 2015; 8(5): pii: e003061. https://doi.org/10.1161/CIRCIMAGING.114.003061
- 5Stillman AE, Oudkerk M, Bluemke DA, et al. Imaging the myocardial ischemic cascade. Int J Cardiovasc Imaging. 2018; 34(8): 1249-1263.
- 6Nagel E, Greenwood JP, McCann GP, et al. MR-INFORM Investigators. N Engl J Med. 2019; 380(25): 2418-2428. https://doi.org/10.1056/NEJMoa1716734.
- 7Berry C, Mangion K, Corcoran D. Magnetic resonance perfusion imaging to guide management of patients with stable ischemic heart disease. JACC Cardiovasc Imaging. 2018; 11(7): 997-999.
- 8Buechel ER, Balmer C, Bauersfeld U, Kellenberger CJ, Schwitter J. Feasibility of perfusion cardiovascular magnetic resonance in paediatric patients. J Cardiovasc Magn Reson. 2009; 11: 51.
- 9Partington SL, Valente AM, Landzberg M, Grant F, Di Carli MF, Dorbala S. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease. J Nucl Cardiol. 2016; 23(1): 45-63.
- 10Strigl S, Beroukhim R, Valente AM, et al. Feasibility of dobutamine stress cardiovascular magnetic resonance imaging in children. J Magn Reson Imaging. 2009; 29(2): 313-319.
- 11Hauser M, Bengel FM, Kuhn A, et al. Myocardial blood flow and flow reserve after coronary reimplantation in patients after arterial switch and ross operation. Circulation. 2001; 103(14): 1875-1880.
- 12Noel CV, Krishnamurthy R, Masand P, et al. Myocardial stress perfusion MRI: experience in pediatric and young-adult patients following arterial switch operation utilizing regadenoson. Pediatr Cardiol. 2018; 39(6): 1249-1257.
- 13Raimondi F, Aquaro GD, De Marchi D, et al. Cardiac magnetic resonance myocardial perfusion after arterial switch for transposition of great arteries. JACC Cardiovasc Imaging. 2018; 11(5): 778-779.
- 14Noel CV, Krishnamurthy R, Moffett B, Krishnamurthy R. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson. Pediatr Radiol. 2017; 47(3): 280-289.
- 15Alsoufi B, Fadel B, Bulbul Z, et al. Cardiac reoperations following the Ross procedure in children: spectrum of surgery and reoperation results. Eur J Cardiothorac Surg. 2012; 42(1): 25-30; discussion 30–21.
- 16Schmitt B, Bauer S, Kutty S, et al. Myocardial perfusion, scarring, and function in anomalous left coronary artery from the pulmonary artery syndrome: a long-term analysis using magnetic resonance imaging. Ann Thorac Surg. 2014; 98(4): 1425-1436.
- 17Mery CM, Lawrence SM, Krishnamurthy R, et al. Anomalous aortic origin of a coronary artery: toward a standardized approach. Semin Thorac Cardiovasc Surg. 2014; 26(2): 110-122.
- 18Uebleis C, Groebner M, von Ziegler F, et al. Combined anatomical and functional imaging using coronary CT angiography and myocardial perfusion SPECT in symptomatic adults with abnormal origin of a coronary artery. Int J Cardiovasc Imaging. 2012; 28(7): 1763-1774.
- 19Cremer PC, Mentias A, Koneru S, et al. Risk stratification with exercise N(13)-ammonia PET in adults with anomalous right coronary arteries. Open Heart. 2016; 3(2):e000490.
- 20Noel C. Cardiac stress MRI evaluation of anomalous aortic origin of a coronary artery. Congenit Heart Dis. 2017; 12(5): 627-629.
- 21McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017; 135(17): e927-e999.
- 22Friedman KG, Gauvreau K, Hamaoka-Okamoto A, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc. 2016; 5(9): pii: e003289. https://doi.org/10.1161/JAHA.116.003289
- 23Tsuda E, Hamaoka K, Suzuki H, et al. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J. 2014; 167(2): 249-258.
- 24Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000; 36(1): 255-261.
- 25Dodge-Khatami A, Tulevski II, Bennink GB, et al. Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally corrected transposition using MRI dobutamine stress testing. Ann Thorac Surg. 2002; 73(6): 1759-1764.
- 26Tulevski II, Lee PL, Groenink M, et al. Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the great arteries: evaluation with magnetic resonance imaging. Int J Card Imaging. 2000; 16(6): 471-478.
- 27Leppo JA. Comparison of pharmacologic stress agents. J Nucl Cardiol. 1996; 3(6 Pt 2): S22-S26.
- 28Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004; 110(7): 835-842.
- 29Paetsch I, Jahnke C, Fleck E, Nagel E. Current clinical applications of stress wall motion analysis with cardiac magnetic resonance imaging. Eur J Echocardiogr. 2005; 6(5): 317-326.
- 30Lim WH, Koo BK, Nam CW, et al. Variability of fractional flow reserve according to the methods of hyperemia induction. Catheter Cardiovasc Interv. 2015; 85(6): 970-976.
- 31Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology. 2009; 111(4): 904-915.
- 32Karamitsos TD, Arnold JR, Pegg TJ, et al. Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease. Int J Cardiovasc Imaging. 2009; 25(3): 277-283.
- 33Brink HL, Dickerson JA, Stephens JA, Pickworth KK. Comparison of the safety of adenosine and regadenoson in patients undergoing outpatient cardiac stress testing. Pharmacotherapy. 2015; 35(12): 1117-1123.
- 34Mahmarian JJ, Peterson LE, Xu J, et al. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. J Nucl Cardiol. 2015; 22(2): 248-261.
- 35Farzaneh-Far A, Shaw LK, Dunning A, Oldan JD, O'Connor CM, Borges-Neto S. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. J Nucl Cardiol. 2015; 22(4): 600-607.
- 36Hojjati MR, Muthupillai R, Wilson JM, Preventza OA, Cheong BY. Assessment of perfusion and wall-motion abnormalities and transient ischemic dilation in regadenoson stress cardiac magnetic resonance perfusion imaging. Int J Cardiovasc Imaging. 2014; 30(5): 949-957.
- 37Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007; 14(5): 645-658.
- 38Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J. 2004; 25(14): 1230-1236.
- 39van Dijk R, Kuijpers D, Kaandorp T, et al. Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping. Int J Cardiovasc Imaging. 2017; 33(11): 1753-1759.
- 40Greenwood JP, Motwani M, Maredia N, et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation. 2014; 129(10): 1129-1138.
- 41Robbers-Visser D, Luijnenburg SE, van den Berg J, Moelker A, Helbing WA. Stress imaging in congenital cardiac disease. Cardiol Young. 2009; 19(6): 552-562.
- 42Heitner JF, Klem I, Rasheed D, et al. Stress cardiac MR imaging compared with stress echocardiography in the early evaluation of patients who present to the emergency department with intermediate-risk chest pain. Radiology. 2014; 271(1): 56-64.
- 43Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. J Am Med Assoc. 2012; 307(22): 2400-2409.
- 44Shah R, Heydari B, Coelho-Filho O, et al. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation. 2013; 128(6): 605-614.
- 45Barber NJ, Ako EO, Kowalik GT, et al. Magnetic resonance-augmented cardiopulmonary exercise testing: comprehensively assessing exercise intolerance in children with cardiovascular disease. Circ Cardiovasc Imaging. 2016; 9(12): pii: e005282.
- 46Claessen G, La Gerche A, Van De Bruaene A, et al. Heart rate reserve in fontan patients: chronotropic incompetence or hemodynamic limitation? J Am Heart Assoc. 2019; 8(9):e012008.
- 47Nezafat M, Henningsson M, Ripley DP, et al. Coronary MR angiography at 3T: fat suppression versus water-fat separation. Magma. 2016; 29(5): 733-738.
- 48Abidov A, Dilsizian V, Doukky R, et al. Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR. J Cardiovasc Magn Reson. 2018; 20(1): 87.
- 49Vijarnsorn C, Noga M, Schantz D, Pepelassis D, Tham EB. Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children. Int J Cardiovasc Imaging. 2017; 33(5): 699-709.
- 50Ntsinjana HN, Tann O, Hughes M, et al. Utility of adenosine stress perfusion CMR to assess paediatric coronary artery disease. Eur Heart J Cardiovasc Imaging. 2017; 18(8): 898-905.
- 51Campbell MJ, Barker P, Darty S, Kim RJ. Adenosine stress perfusion CMR in young children: assessment of optimal imaging parameters. J Cardiovasc Magn Reson. 2013; 15(1): P298.
10.1186/1532-429X-15-S1-P298 Google Scholar
- 52Oosterhof T, Tulevski I, Roest A, et al. Disparity between dobutamine stress and physical exercise magnetic resonance imaging in patients with an intra-atrial correction for transposition of the great arteries. J Cardiovasc Magn Reson. 2005; 7(2): 383-389.
- 53Prakash A, Powell AJ, Krishnamurthy R, Geva T. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol. 2004; 93(5): 657-661.
- 54van der Zedde J, Oosterhof T, Tulevski II, Vliegen HW, Mulder BJ. Comparison of segmental and global systemic ventricular function at rest and during dobutamine stress between patients with transposition and congenitally corrected transposition. Cardiol Young. 2005; 15(2): 148-153.
- 55Tulevski II, van der Wall EE, Groenink M, et al. Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol. 2002; 89(9): 1077-1081.
